Biofrontera Inc.
- BFRI
- NASDAQ
- Medical - Pharmaceuticals
- Dermatology Drugs
- Photodynamic Therapy (Ameluz)
$0.81
Today −1.94%Quote Oct 19, 2026, 08:00 PM UTC
−33.74%over the last month
Max drawdown −37.8%From 1-month high −37.8%3 months −21.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Biofrontera
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Employees
89
Founded
2015
Market value
$12.0M
Quote Oct 19
Floor
$0.80
1.2% below price
Resistance
$0.82
1.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BFRIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free